NCT00213876View on ClinicalTrials.gov

Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain Tumours

CompletedOBSERVATIONAL

Enrollment

189

Participants

Timeline

Start Date

February 29, 2004

Study Completion Date

August 31, 2011

Conditions

Oligodendrogliomas

Trial Locations (1)

Unknown

Natacha Entz-Werle, Strasbourg

All Listed Sponsors

lead

University Hospital, Strasbourg, France

OTHER

NCT00213876 - Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain Tumours | Biotech Hunter | Biotech Hunter